Literature DB >> 3975623

Regional myocardial substrate uptake in hypertensive rats: a quantitative autoradiographic measurement.

Y Yonekura, A B Brill, P Som, K Yamamoto, S C Srivastava, J Iwai, D R Elmaleh, E Livni, H W Strauss, M M Goodman.   

Abstract

Severe hypertension causes global and regional changes in myocardial perfusion and substrate utilization. Regional perfusion and fatty acid utilization were evaluated by dual-tracer autoradiography in normotensive and hypertensive rats of the Dahl strain. The regional distributions of perfusion and fatty acid utilization were homogeneous in normotensive rats. Severe hypertension was associated with a homogeneous pattern of regional perfusion, but fatty acid utilization was focally decreased in the free wall of the left ventricle. The decrease in fatty acid uptake was associated with a concomitant increase in glucose utilization. These findings suggest that severe hypertension is associated with uniform myocardial perfusion and focal alterations in the substrates used for the performance of myocardial work.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3975623     DOI: 10.1126/science.3975623

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  37 in total

1.  Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency.

Authors:  Lisa de las Fuentes; Pablo F Soto; Brian P Cupps; Michael K Pasque; Pilar Herrero; Robert J Gropler; Alan D Waggoner; Victor G Dávila-Román
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

2.  Altered energy supply to the pump function of the isolated heart of spontaneously hypertensive rats.

Authors:  Vladimir L Lakomkin; Irina M Studneva; Oleg I Pisarenko; Anton Yu Postnov; Valeri I Kapelko
Journal:  Exp Clin Cardiol       Date:  2003

Review 3.  Myocardial imaging with 123I-BMIPP in patients with congestive heart failure.

Authors:  Y Ishida; Y Yasumura; N Nagaya; K Fukuchi; K Komamura; M Takamiya; K Miyatake
Journal:  Int J Card Imaging       Date:  1999-02

4.  Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.

Authors:  P Nuutila; M J Knuuti; O J Heinonen; U Ruotsalainen; M Teräs; J Bergman; O Solin; H Yki-Järvinen; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 5.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

6.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

7.  Both total chain length and position of dimethyl-branching effect the myocardial uptake and retention of radioiodinated analogues of 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid (DMIPP).

Authors:  F F Knapp; M M Goodman; G Kirsch; S N Reske; J Kropp; H J Biersack; K R Ambrose; C R Lambert; A Goudonnet
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

8.  The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover.

Authors:  J Michael O'Donnell; Aaron D Fields; Natalia Sorokina; E Douglas Lewandowski
Journal:  J Mol Cell Cardiol       Date:  2007-11-24       Impact factor: 5.000

9.  (3H/14C)beta-methylheptadecanoic acid subcellular distribution and lipid incorporation in mouse heart.

Authors:  E Livni; S Ito; A I Kassis; D R Elmaleh
Journal:  Lipids       Date:  1990-04       Impact factor: 1.880

10.  Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism.

Authors:  M Kawamoto; N Tamaki; Y Yonekura; E Tadamura; Y Fujibayashi; Y Magata; R Nohara; S Sasayama; K Ikekubo; H Kato
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.